Company Filing History:
Years Active: 2005-2014
Title: Claude Jarakae Jensen: Innovator in Fortified Food and Dietary Supplements
Introduction
Claude Jarakae Jensen is a notable inventor based in Cedar Hills, Utah, with a remarkable portfolio of 13 patents. His work primarily focuses on the development of fortified food and dietary supplement products aimed at enhancing physiological health.
Latest Patents
Jensen's latest patents include innovative embodiments that relate to fortified food and dietary supplement products designed to produce desirable physiological improvements. One of his significant inventions involves the administration of products enhanced with iridoids, which are compounds known for their health benefits. Another patent emphasizes the use of plant products and iridoids in dietary supplements. A study conducted on a beverage containing noni fruit, Cornelian cherries, and olive leaf extract revealed high levels of iridoids, such as asperulosidic acid and oleuropein. The research demonstrated remarkable in vitro antioxidant activity and positive in vivo bioactivities in type 2 diabetic rats, showcasing the potential of his inventions to improve health outcomes.
Career Highlights
Throughout his career, Jensen has made significant contributions to the field of dietary supplements. He has worked with companies such as Morinda, Inc. and Tahitian Noni International, Inc., where he has applied his expertise in developing health-enhancing products. His innovative approach has led to advancements in the formulation of dietary supplements that leverage the benefits of natural ingredients.
Collaborations
Jensen has collaborated with notable individuals in his field, including Afa Kehaati Palu and Brett Justin West. These partnerships have further enriched his work and contributed to the success of his inventions.
Conclusion
Claude Jarakae Jensen stands out as an influential inventor in the realm of fortified food and dietary supplements. His dedication to improving health through innovative products is evident in his extensive patent portfolio and collaborative efforts.